Colorectal Cancer: A Biobank of Patient-derived Xenografts

According to GLOBOCAN 2018 data, colorectal cancer (CRC) is the third most deadly and fourth most commonly diagnosed cancer in the world. There were nearly 2 million new cases and about 1 million deaths in 2018. The incidence of...

A Living Biobank Of Ovarian Cancer – A Model For Drug Discovery

Synthetic lethality is a circumstance in which a drug is selectively deadly to cancer cells due to the mutations and genetic changes that have occurred during oncogenesis and progression. Oftentimes a cancer will lose redundancy, that is it will jettison...
Biobanking and colorectal cancer tissues

Biobanking Science: Biobanking Samples for Colorectal Cancer

Colorectal cancer is the third most common cancer, affecting 1.8 million new patients and causing 862,000 deaths every year (1). Studies show that eating processed or red meat and drinking alcohol may increase the risk for colorectal cancer (2)....

🔥 Most Popular

Featured Vendors